Abstract
肾细胞癌是泌尿系统常见恶性肿瘤，现有的病理学分型体系未能完全满足临床对肾细胞癌患者治疗需求和预后判断。随着测序技术的不断进步和分子标志物的引入，形态学结合分子诊断应用于临床可显著提高肾细胞癌分型对疾病预后判断的准确性。但目前仍缺乏可供临床实际应用的分子分型方法，基于组学差异的肿瘤亚型分类可能是未来的研究方向。.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua bing li xue za zhi = Chinese journal of pathology
Paper Title
Journal
Date
